A carregar...
The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis
BACKGROUND: OnabotulinumtoxinA has been shown to reduce headache-days among patients with chronic migraine (CM). The objective of this analysis was to determine whether onabotulinumtoxinA has an impact on headache-day severity in patients with CM among those patients who were deemed non-responders b...
Na minha lista:
| Publicado no: | J Headache Pain |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Milan
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5539058/ https://ncbi.nlm.nih.gov/pubmed/28766236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-017-0784-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|